Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Ivan S. Pradipta is active.

Publication


Featured researches published by Ivan S. Pradipta.


North American Journal of Medical Sciences | 2013

Antibiotic Resistance in Sepsis Patients: Evaluation and Recommendation of Antibiotic Use

Ivan S. Pradipta; Dian Chairunnisa Sodik; Keri Lestari; Ida Parwati; Eli Halimah; Ajeng Diantini; Rizky Abdulah

Background: The appropriate selection of empirical antibiotics based on the pattern of local antibiotic resistance can reduce the mortality rate and increase the rational use of antibiotics. Aims: We analyze the pattern of antibiotic use and the sensitivity patterns of antibiotics to support the rational use of antibiotics in patients with sepsis. Materials and Methods: A retrospective observational study was conducted in adult sepsis patient at one of Indonesian hospital during January-December 2011. Data were collected from the hospital medical record department. Descriptive analysis was used in the processing and interpretation of data. Results: A total of 76 patients were included as research subjects. Lung infection was the highest source of infection. In the 66.3% of clinical specimens that were culture positive for microbes, Klebsiella pneumoniae, Escherichia coli, Staphylococcus hominis were detected with the highest frequency. The six most frequently used antibiotics, levofloxacin, ceftazidime, ciprofloxacin, cefotaxime, ceftriaxone, and erythromycin, showed an average resistance above 50%. Conclusions: The high use of antibiotic with a high level resistance requires a policy to support its rational use. Local microbial pattern based on site infection and pattern of antibiotics sensitivity test can be used as supporting data to optimize appropriateness of empirical antibiotics therapy in sepsis patients.


Journal of Family and Community Medicine | 2015

Three years of antibacterial consumption in Indonesian Community Health Centers: The application of anatomical therapeutic chemical/defined daily doses and drug utilization 90% method to monitor antibacterial use

Ivan S. Pradipta; Elis Ronasih; Arrum D Kartikawati; Hartanto Hartanto; Rizki Amelia; Ellin Febrina; Rizky Abdulah

Context: Irrational use of antibacterial drugs in Community Health-Care Centers (CHCs) may lead to increased resistance, morbidity, and mortality. Aims: The aim of this study was to determine patterns of antibacterial use at CHCs in a district of Indonesia and use this as data for an antibiotic policy. Settings and Design: The observational-descriptive study was conducted in a district of Indonesia to obtain antibacterial use from 2008 to 2010. Subjects and Methods: The data obtained from the report on the use of medicines were classified and processed using the anatomical therapeutic chemical (ATC) and defined daily doses (DDD) method, with DDD/1000 patients as a unit measurement. The number of patients was obtained from attending patients in that research period. The most abundant antibacterial drugs use segment was identified by the drug utilization 90% (DU90%) method. Statistical Analysis Used: Descriptive analysis were performed in this study. Results: Fourteen kinds of antibacterial drugs were used in 61 CHCs. The total of antibacterial drug use during the period 2008-2010 was 871.36 DDD/1000 patients/day. Declining antibacterial use was observed between 2008 and 2010. Six kinds of antibacterial drugs were the most commonly used. The data show that the average use per visit was as high as 24.41 DDD. Conclusions: Amoxicillin, sulfamethoxazole and trimethoprim are antibacterials that have to be reconsidered by physicians for use in the Bandung CHC. The high use of antibacterial drugs, as described in the study, can be used as reference to develop an antimicrobial stewardship program and increase awareness of resistance, adverse drug reaction and drug interaction of antibacterial drugs.


Journal of Clinical Pharmacy and Therapeutics | 2015

Off-label paediatric drug use in an Indonesian community setting.

Rizky Abdulah; M. A. Khairinisa; A. A. Pratiwi; Melisa I. Barliana; Ivan S. Pradipta; Eli Halimah; Ajeng Diantini; Keri Lestari

Off‐label medication is often used in the treatment of paediatric patients. However, it should be restricted due to the lack of evidence related to its efficacy and safety. Little is known about the frequency of off‐label drug use or the degree of scientific evidence supporting this practice in Indonesia. The aim of this study was to investigate the off‐label prescribing practice for paediatric patients in Bandung city, Indonesia.


Psychology Research and Behavior Management | 2017

DNA methyltransferase 3A gene polymorphism contributes to daily life stress susceptibility

Melisa I. Barliana; Shintya N Amalya; Ivan S. Pradipta; Sofa D. Alfian; Arif Sw Kusuma; Tiana Milanda; Rizky Abdulah

Daily life stress markedly affects the response toward stressful stimuli. DNA methy-lation is one of the factors that regulate this response, and is a normal mechanism of somatic cell growth, but its regulatory gene variations may cause alterations in the stress response. The aim of the present study was to investigate genotypic variants of the DNA methyltransferase 3A (DNMT3A) gene in 129 healthy subjects and evaluate its association with daily life stress. Blood samples were collected, and genomic DNA was isolated. DNA was amplified using specific tetra primers for DNMT3A (C/T) rs11683424 and visualized following 2% agarose gel electrophoresis. The association of DNMT3A genetic variants with daily life stress was analyzed using the Kessler Psychological Distress Scale (K10). We observed that the distribution of subjects with genotype CC (wild type), CT (heteromutant), and TT (homomutant) was 13.95%, 81.4%, and 4.65%, respectively. Genetic variations significantly affected the daily life stress condition (p=0.04) in Indonesian healthy subjects, but most of the subjects with the CT phenotype were classified in a stress condition.


Biomedical Reports | 2015

Induction of caspase cascade pathway by kaempferol-3-O-rhamnoside in LNCaP prostate cancer cell lines

Eli Halimah; Ajeng Diantini; Dika P. Destiani; Ivan S. Pradipta; Herri S. Sastramihardja; Keri Lestari; Anas Subarnas; Rizky Abdulah; Hiroshi Koyama


Southeast Asian Journal of Tropical Medicine and Public Health | 2014

Assessment of patient care indicators at community pharmacies in Bandung City, Indonesia.

Rizky Abdulah; Melisa I. Barliana; Ivan S. Pradipta; Eli Halimah; Ajeng Diantini; Keri Lestari


Indonesian Journal of Clinical Pharmacy | 2014

Analisis Minimalisasi Biaya Penggunaan Antibiotik Empirik Pasien Sepsis Sumber Infeksi Pernapasan

Okky S. Purwanti; Rizky Abdulah; Ivan S. Pradipta; Cherry Rahayu


Archive | 2013

Microbial and Resistance Profile in Isolate from Adult Sepsis Patients: An Observational Study at an Indonesian Private Hospital during 2009-2012

Ivan S. Pradipta; Ajeng T. Sandiana; Eli Halimah; Keri Lestari; Rizky Abdulah


Indonesian Journal of Clinical Pharmacy | 2013

Analisis Minimalisasi Biaya Antibiotik Pasien Sepsis Salah Satu Rumah Sakit Kota Bandung

Okky S. Purwanti; Rano K. Sinuraya; Ivan S. Pradipta; Rizky Abdulah


Indonesian Journal of Clinical Pharmacy | 2013

Peresepan Obat-obat Off-Label pada Pasien Anak Usia 0 Hingga 2 Tahun di Apotek Kota Bandung

Ami A. Pratiwi; Miski A. Khairinnisa; Sofa D. Alfian; Akhmad Priyadi; Ivan S. Pradipta; Rizky Abdulah

Collaboration


Dive into the Ivan S. Pradipta's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Eli Halimah

Padjadjaran University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge